The results of CAPRIE, IST and CAST

Thrombosis Research

Volumn 92, Issue 1 SUPPL. 1, 1998, Pages

  Dippel, Diederik W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aspirin; Clopidogrel; Ischaemia; Secondary prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ARTERY DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STROKE; TREATMENT OUTCOME;

ASPIRIN; CEREBROVASCULAR DISORDERS; DOUBLE-BLIND METHOD; HUMANS; ISCHEMIA; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; TICLOPIDINE;

EID: 0032531239     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00102-9     Document Type: Conference Paper

References (12)

1. Algra A., Van Gun J. Aspirin at any dose above 30 mg offers only modest protection against cerebral ischaemia. J Neurol Neurosurg Psychiatry. 60:1996;197-199.
2. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients Br Med J. 308:1994;81-106.
3. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet. 348:1996;633-688.
4. Hass W.K., Easton J.D., Adams H.P. Jr., Pryse-Phillips W., Molony B.A., Anderson S., Kamm B. A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med. 321:1989;501-507.
5. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Roberts RS, Sicurella J, Turpie AG. The Canadian American Ticlopidine Study (CATS) in thrombo-embolic stroke. Lancet 1989;i:1215-20.
6. International Stroke Trial Collaborative Group The International Stroke Trial (IST). A randomised trial of aspirin, subcutaneous heparin, both or neither among 19,435 patients with acute ischaemic stroke Lancet. 349:1997;1569-1581.
7. Chinese Acute Stroke Trial Collaborative Group CAST. A randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke Lancet. 349:1997;1641-1649.
8. Multicentre Acute Stroke Trial-Italy, MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 346:1995;1509-1514.
9. Diener H., Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the prevention of stroke. J Neurol Sci. 14:1996;1-13.
10. Gortier JW, Algra A, Van Gun J, Kappelle LJ, Koudstaal PJ, Tjeerdsma HC. SPIRIT: Predictors of anticoagulant bleeding complication in patients after cerebral ischemia. Cerebrovasc Dis 1997;7(Suppl 4).
11. Van Kooten F., Ciabattoni G., Patrono C., Schmitz P., Van Gun J., Koudstaal P. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 25:1994;278-281.
12. Van Kooten F., Ciabattoni G., Patrono C., Dippel D.W.J., Koudstaal P.J. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke. 28:1997;1557-1563.